img

Global Immunoglobulin Market Insights, Forecast to 2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Immunoglobulin Market Insights, Forecast to 2034

Global Immunoglobulin market is expected to reach to US$ million in 2024, with a positive growth of %, compared with US$ million in 2022. Backed with the increasing demand from downstream industries, Immunoglobulin industry is evaluated to reach US$ million in 2029. The CAGR will be % during 2024 to 2029.
Globally, Immunoglobulin key manufacturers include Baxter, CSL, Grifols, Octapharma, Biotest, China National Pharmaceutical Group, CTBB, Hualan Bio and RAAS, etc. Baxter, CSL, Grifols are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Immunoglobulin were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2029 and the sales share will be % in 2029. Moreover, China, plays a key role in the whole Immunoglobulin market and estimated to attract more attentions from industry insiders and investors.
Immunoglobulin can be divided into Intramuscular Injection Human Immunoglobulin and Intravenous Injection Human Immunoglobulin, etc. Intramuscular Injection Human Immunoglobulin is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2029.
Immunoglobulin is widely used in various fields, such as Prevention of Measles, Infectious Hepatitis and Primary Immunoglobulin Deficiency,, etc. Prevention of Measles provides greatest supports to the Immunoglobulin industry development. In 2022, global % sales of Immunoglobulin went into Prevention of Measles filed and the proportion will reach to % in 2029.
Report Covers
This report presents an overview of global Immunoglobulin market from 2018 to 2029, aiming to help readers to get a comprehensive understanding of global Immunoglobulin market with multiple angles. Items like regional sales, revenue from 2018 to 2029 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2024 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2029 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Baxter
CSL
Grifols
Octapharma
Biotest
China National Pharmaceutical Group
CTBB
Hualan Bio
RAAS
Shanxi Kangbao Biological
Shuanglin Bio Pharm
Sichuan Yuanda Shuyang Pharmaceutical
Boya Bio
Jiade Bio
Weilun Bio
Segment by Type
Intramuscular Injection Human Immunoglobulin
Intravenous Injection Human Immunoglobulin

Segment by Application


Prevention of Measles
Infectious Hepatitis
Primary Immunoglobulin Deficiency

Segment by Region


US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline


Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2029
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Immunoglobulin plant distribution, commercial date of Immunoglobulin, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2029 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2029 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2029 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2029
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2029 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2029
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2029 in China. Product sales and revenue analysis of China from 2018 to 2029
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2029 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2029
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2029 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2029.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Immunoglobulin introduction, etc. Immunoglobulin Sales, Revenue, Price and Gross Margin of each company from 2018 to 2024
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14Mr Accuracy reports Conclusions of Immunoglobulin
Chapter 15Methodology and Data Sources adopted by Mr Accuracy reports

Table of Content

1 Study Coverage
1.1 Immunoglobulin Product Introduction
1.2 Market by Type
1.2.1 Global Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Intramuscular Injection Human Immunoglobulin
1.2.3 Intravenous Injection Human Immunoglobulin
1.3 Market by Application
1.3.1 Global Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Prevention of Measles
1.3.3 Infectious Hepatitis
1.3.4 Primary Immunoglobulin Deficiency
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Immunoglobulin Sales Estimates and Forecasts 2018-2029
2.2 Global Immunoglobulin Revenue by Region
2.2.1 Global Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029
2.2.2 Global Immunoglobulin Revenue by Region (2018-2024)
2.2.3 Global Immunoglobulin Revenue by Region (2024-2029)
2.2.4 Global Immunoglobulin Revenue Market Share by Region (2018-2029)
2.3 Global Immunoglobulin Sales Estimates and Forecasts 2018-2029
2.4 Global Immunoglobulin Sales by Region
2.4.1 Global Immunoglobulin Sales by Region: 2018 VS 2022 VS 2029
2.4.2 Global Immunoglobulin Sales by Region (2018-2024)
2.4.3 Global Immunoglobulin Sales by Region (2024-2029)
2.4.4 Global Immunoglobulin Sales Market Share by Region (2018-2029)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufactures
3.1 Global Immunoglobulin Sales by Manufacturers
3.1.1 Global Immunoglobulin Sales by Manufacturers (2018-2024)
3.1.2 Global Immunoglobulin Sales Market Share by Manufacturers (2018-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Immunoglobulin in 2022
3.2 Global Immunoglobulin Revenue by Manufacturers
3.2.1 Global Immunoglobulin Revenue by Manufacturers (2018-2024)
3.2.2 Global Immunoglobulin Revenue Market Share by Manufacturers (2018-2024)
3.2.3 Global Top 10 and Top 5 Companies by Immunoglobulin Revenue in 2022
3.3 Global Key Players of Immunoglobulin, Industry Ranking, 2021 VS 2022 VS 2024
3.4 Global Immunoglobulin Sales Price by Manufacturers
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Immunoglobulin, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Immunoglobulin, Product Offered and Application
3.8 Global Key Manufacturers of Immunoglobulin, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Immunoglobulin Sales by Type
4.1.1 Global Immunoglobulin Historical Sales by Type (2018-2024)
4.1.2 Global Immunoglobulin Forecasted Sales by Type (2024-2029)
4.1.3 Global Immunoglobulin Sales Market Share by Type (2018-2029)
4.2 Global Immunoglobulin Revenue by Type
4.2.1 Global Immunoglobulin Historical Revenue by Type (2018-2024)
4.2.2 Global Immunoglobulin Forecasted Revenue by Type (2024-2029)
4.2.3 Global Immunoglobulin Revenue Market Share by Type (2018-2029)
4.3 Global Immunoglobulin Price by Type
4.3.1 Global Immunoglobulin Price by Type (2018-2024)
4.3.2 Global Immunoglobulin Price Forecast by Type (2024-2029)
5 Market Size by Application
5.1 Global Immunoglobulin Sales by Application
5.1.1 Global Immunoglobulin Historical Sales by Application (2018-2024)
5.1.2 Global Immunoglobulin Forecasted Sales by Application (2024-2029)
5.1.3 Global Immunoglobulin Sales Market Share by Application (2018-2029)
5.2 Global Immunoglobulin Revenue by Application
5.2.1 Global Immunoglobulin Historical Revenue by Application (2018-2024)
5.2.2 Global Immunoglobulin Forecasted Revenue by Application (2024-2029)
5.2.3 Global Immunoglobulin Revenue Market Share by Application (2018-2029)
5.3 Global Immunoglobulin Price by Application
5.3.1 Global Immunoglobulin Price by Application (2018-2024)
5.3.2 Global Immunoglobulin Price Forecast by Application (2024-2029)
6 US & Canada
6.1 US & Canada Immunoglobulin Market Size by Type
6.1.1 US & Canada Immunoglobulin Sales by Type (2018-2029)
6.1.2 US & Canada Immunoglobulin Revenue by Type (2018-2029)
6.2 US & Canada Immunoglobulin Market Size by Application
6.2.1 US & Canada Immunoglobulin Sales by Application (2018-2029)
6.2.2 US & Canada Immunoglobulin Revenue by Application (2018-2029)
6.3 US & Canada Immunoglobulin Market Size by Country
6.3.1 US & Canada Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
6.3.2 US & Canada Immunoglobulin Sales by Country (2018-2029)
6.3.3 US & Canada Immunoglobulin Revenue by Country (2018-2029)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Immunoglobulin Market Size by Type
7.1.1 Europe Immunoglobulin Sales by Type (2018-2029)
7.1.2 Europe Immunoglobulin Revenue by Type (2018-2029)
7.2 Europe Immunoglobulin Market Size by Application
7.2.1 Europe Immunoglobulin Sales by Application (2018-2029)
7.2.2 Europe Immunoglobulin Revenue by Application (2018-2029)
7.3 Europe Immunoglobulin Market Size by Country
7.3.1 Europe Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
7.3.2 Europe Immunoglobulin Sales by Country (2018-2029)
7.3.3 Europe Immunoglobulin Revenue by Country (2018-2029)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Immunoglobulin Market Size
8.1.1 China Immunoglobulin Sales (2018-2029)
8.1.2 China Immunoglobulin Revenue (2018-2029)
8.2 China Immunoglobulin Market Size by Application
8.2.1 China Immunoglobulin Sales by Application (2018-2029)
8.2.2 China Immunoglobulin Revenue by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Immunoglobulin Market Size by Type
9.1.1 Asia Immunoglobulin Sales by Type (2018-2029)
9.1.2 Asia Immunoglobulin Revenue by Type (2018-2029)
9.2 Asia Immunoglobulin Market Size by Application
9.2.1 Asia Immunoglobulin Sales by Application (2018-2029)
9.2.2 Asia Immunoglobulin Revenue by Application (2018-2029)
9.3 Asia Immunoglobulin Sales by Region
9.3.1 Asia Immunoglobulin Revenue by Region: 2018 VS 2022 VS 2029
9.3.2 Asia Immunoglobulin Revenue by Region (2018-2029)
9.3.3 Asia Immunoglobulin Sales by Region (2018-2029)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Immunoglobulin Market Size by Type
10.1.1 Middle East, Africa and Latin America Immunoglobulin Sales by Type (2018-2029)
10.1.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2018-2029)
10.2 Middle East, Africa and Latin America Immunoglobulin Market Size by Application
10.2.1 Middle East, Africa and Latin America Immunoglobulin Sales by Application (2018-2029)
10.2.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2018-2029)
10.3 Middle East, Africa and Latin America Immunoglobulin Sales by Country
10.3.1 Middle East, Africa and Latin America Immunoglobulin Revenue by Country: 2018 VS 2022 VS 2029
10.3.2 Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2018-2029)
10.3.3 Middle East, Africa and Latin America Immunoglobulin Sales by Country (2018-2029)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Company Profiles
11.1 Baxter
11.1.1 Baxter Company Information
11.1.2 Baxter Overview
11.1.3 Baxter Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.1.4 Baxter Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Baxter Recent Developments
11.2 CSL
11.2.1 CSL Company Information
11.2.2 CSL Overview
11.2.3 CSL Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.2.4 CSL Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 CSL Recent Developments
11.3 Grifols
11.3.1 Grifols Company Information
11.3.2 Grifols Overview
11.3.3 Grifols Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.3.4 Grifols Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Grifols Recent Developments
11.4 Octapharma
11.4.1 Octapharma Company Information
11.4.2 Octapharma Overview
11.4.3 Octapharma Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.4.4 Octapharma Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Octapharma Recent Developments
11.5 Biotest
11.5.1 Biotest Company Information
11.5.2 Biotest Overview
11.5.3 Biotest Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.5.4 Biotest Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Biotest Recent Developments
11.6 China National Pharmaceutical Group
11.6.1 China National Pharmaceutical Group Company Information
11.6.2 China National Pharmaceutical Group Overview
11.6.3 China National Pharmaceutical Group Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.6.4 China National Pharmaceutical Group Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 China National Pharmaceutical Group Recent Developments
11.7 CTBB
11.7.1 CTBB Company Information
11.7.2 CTBB Overview
11.7.3 CTBB Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.7.4 CTBB Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 CTBB Recent Developments
11.8 Hualan Bio
11.8.1 Hualan Bio Company Information
11.8.2 Hualan Bio Overview
11.8.3 Hualan Bio Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.8.4 Hualan Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Hualan Bio Recent Developments
11.9 RAAS
11.9.1 RAAS Company Information
11.9.2 RAAS Overview
11.9.3 RAAS Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.9.4 RAAS Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 RAAS Recent Developments
11.10 Shanxi Kangbao Biological
11.10.1 Shanxi Kangbao Biological Company Information
11.10.2 Shanxi Kangbao Biological Overview
11.10.3 Shanxi Kangbao Biological Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.10.4 Shanxi Kangbao Biological Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Shanxi Kangbao Biological Recent Developments
11.11 Shuanglin Bio Pharm
11.11.1 Shuanglin Bio Pharm Company Information
11.11.2 Shuanglin Bio Pharm Overview
11.11.3 Shuanglin Bio Pharm Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.11.4 Shuanglin Bio Pharm Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Shuanglin Bio Pharm Recent Developments
11.12 Sichuan Yuanda Shuyang Pharmaceutical
11.12.1 Sichuan Yuanda Shuyang Pharmaceutical Company Information
11.12.2 Sichuan Yuanda Shuyang Pharmaceutical Overview
11.12.3 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.12.4 Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
11.13 Boya Bio
11.13.1 Boya Bio Company Information
11.13.2 Boya Bio Overview
11.13.3 Boya Bio Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.13.4 Boya Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Boya Bio Recent Developments
11.14 Jiade Bio
11.14.1 Jiade Bio Company Information
11.14.2 Jiade Bio Overview
11.14.3 Jiade Bio Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.14.4 Jiade Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 Jiade Bio Recent Developments
11.15 Weilun Bio
11.15.1 Weilun Bio Company Information
11.15.2 Weilun Bio Overview
11.15.3 Weilun Bio Immunoglobulin Sales, Price, Revenue and Gross Margin (2018-2024)
11.15.4 Weilun Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
11.15.5 Weilun Bio Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Immunoglobulin Industry Chain Analysis
12.2 Immunoglobulin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Immunoglobulin Production Mode & Process
12.4 Immunoglobulin Sales and Marketing
12.4.1 Immunoglobulin Sales Channels
12.4.2 Immunoglobulin Distributors
12.5 Immunoglobulin Customers
13 Market Dynamics
13.1 Immunoglobulin Industry Trends
13.2 Immunoglobulin Market Drivers
13.3 Immunoglobulin Market Challenges
13.4 Immunoglobulin Market Restraints
14 Key Findings in The Global Immunoglobulin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Table 2. Major Manufacturers of Intramuscular Injection Human Immunoglobulin
Table 3. Major Manufacturers of Intravenous Injection Human Immunoglobulin
Table 4. Global Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Immunoglobulin Revenue Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 6. Global Immunoglobulin Revenue by Region (2018-2024) & (US$ Million)
Table 7. Global Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 8. Global Immunoglobulin Revenue Market Share by Region (2018-2024)
Table 9. Global Immunoglobulin Revenue Market Share by Region (2024-2029)
Table 10. Global Immunoglobulin Sales Grow Rate (CAGR) by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 11. Global Immunoglobulin Sales by Region (2018-2024) & (K Pcs)
Table 12. Global Immunoglobulin Sales by Region (2024-2029) & (K Pcs)
Table 13. Global Immunoglobulin Sales Market Share by Region (2018-2024)
Table 14. Global Immunoglobulin Sales Market Share by Region (2024-2029)
Table 15. Global Immunoglobulin Sales by Manufacturers (2018-2024) & (K Pcs)
Table 16. Global Immunoglobulin Sales Share by Manufacturers (2018-2024)
Table 17. Global Immunoglobulin Revenue by Manufacturers (2018-2024) & (US$ Million)
Table 18. Global Immunoglobulin Revenue Share by Manufacturers (2018-2024)
Table 19. Global Key Players of Immunoglobulin, Industry Ranking, 2021 VS 2022 VS 2024
Table 20. Immunoglobulin Price by Manufacturers 2018-2024 (USD/Pcs)
Table 21. Global Immunoglobulin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Immunoglobulin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Immunoglobulin as of 2022)
Table 23. Global Key Manufacturers of Immunoglobulin, Manufacturing Base Distribution and Headquarters
Table 24. Global Key Manufacturers of Immunoglobulin, Product Offered and Application
Table 25. Global Key Manufacturers of Immunoglobulin, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Immunoglobulin Sales by Type (2018-2024) & (K Pcs)
Table 28. Global Immunoglobulin Sales by Type (2024-2029) & (K Pcs)
Table 29. Global Immunoglobulin Sales Share by Type (2018-2024)
Table 30. Global Immunoglobulin Sales Share by Type (2024-2029)
Table 31. Global Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 32. Global Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 33. Global Immunoglobulin Revenue Share by Type (2018-2024)
Table 34. Global Immunoglobulin Revenue Share by Type (2024-2029)
Table 35. Immunoglobulin Price by Type (2018-2024) & (USD/Pcs)
Table 36. Global Immunoglobulin Price Forecast by Type (2024-2029) & (USD/Pcs)
Table 37. Global Immunoglobulin Sales by Application (2018-2024) & (K Pcs)
Table 38. Global Immunoglobulin Sales by Application (2024-2029) & (K Pcs)
Table 39. Global Immunoglobulin Sales Share by Application (2018-2024)
Table 40. Global Immunoglobulin Sales Share by Application (2024-2029)
Table 41. Global Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 42. Global Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 43. Global Immunoglobulin Revenue Share by Application (2018-2024)
Table 44. Global Immunoglobulin Revenue Share by Application (2024-2029)
Table 45. Immunoglobulin Price by Application (2018-2024) & (USD/Pcs)
Table 46. Global Immunoglobulin Price Forecast by Application (2024-2029) & (USD/Pcs)
Table 47. US & Canada Immunoglobulin Sales by Type (2018-2024) & (K Pcs)
Table 48. US & Canada Immunoglobulin Sales by Type (2024-2029) & (K Pcs)
Table 49. US & Canada Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 50. US & Canada Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 51. US & Canada Immunoglobulin Sales by Application (2018-2024) & (K Pcs)
Table 52. US & Canada Immunoglobulin Sales by Application (2024-2029) & (K Pcs)
Table 53. US & Canada Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 54. US & Canada Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 55. US & Canada Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 56. US & Canada Immunoglobulin Revenue by Country (2018-2024) & (US$ Million)
Table 57. US & Canada Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 58. US & Canada Immunoglobulin Sales by Country (2018-2024) & (K Pcs)
Table 59. US & Canada Immunoglobulin Sales by Country (2024-2029) & (K Pcs)
Table 60. Europe Immunoglobulin Sales by Type (2018-2024) & (K Pcs)
Table 61. Europe Immunoglobulin Sales by Type (2024-2029) & (K Pcs)
Table 62. Europe Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 63. Europe Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 64. Europe Immunoglobulin Sales by Application (2018-2024) & (K Pcs)
Table 65. Europe Immunoglobulin Sales by Application (2024-2029) & (K Pcs)
Table 66. Europe Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 67. Europe Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 68. Europe Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 69. Europe Immunoglobulin Revenue by Country (2018-2024) & (US$ Million)
Table 70. Europe Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 71. Europe Immunoglobulin Sales by Country (2018-2024) & (K Pcs)
Table 72. Europe Immunoglobulin Sales by Country (2024-2029) & (K Pcs)
Table 73. China Immunoglobulin Sales by Type (2018-2024) & (K Pcs)
Table 74. China Immunoglobulin Sales by Type (2024-2029) & (K Pcs)
Table 75. China Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 76. China Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 77. China Immunoglobulin Sales by Application (2018-2024) & (K Pcs)
Table 78. China Immunoglobulin Sales by Application (2024-2029) & (K Pcs)
Table 79. China Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 80. China Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 81. Asia Immunoglobulin Sales by Type (2018-2024) & (K Pcs)
Table 82. Asia Immunoglobulin Sales by Type (2024-2029) & (K Pcs)
Table 83. Asia Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 84. Asia Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 85. Asia Immunoglobulin Sales by Application (2018-2024) & (K Pcs)
Table 86. Asia Immunoglobulin Sales by Application (2024-2029) & (K Pcs)
Table 87. Asia Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 88. Asia Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 89. Asia Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 90. Asia Immunoglobulin Revenue by Region (2018-2024) & (US$ Million)
Table 91. Asia Immunoglobulin Revenue by Region (2024-2029) & (US$ Million)
Table 92. Asia Immunoglobulin Sales by Region (2018-2024) & (K Pcs)
Table 93. Asia Immunoglobulin Sales by Region (2024-2029) & (K Pcs)
Table 94. Middle East, Africa and Latin America Immunoglobulin Sales by Type (2018-2024) & (K Pcs)
Table 95. Middle East, Africa and Latin America Immunoglobulin Sales by Type (2024-2029) & (K Pcs)
Table 96. Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2018-2024) & (US$ Million)
Table 97. Middle East, Africa and Latin America Immunoglobulin Revenue by Type (2024-2029) & (US$ Million)
Table 98. Middle East, Africa and Latin America Immunoglobulin Sales by Application (2018-2024) & (K Pcs)
Table 99. Middle East, Africa and Latin America Immunoglobulin Sales by Application (2024-2029) & (K Pcs)
Table 100. Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2018-2024) & (US$ Million)
Table 101. Middle East, Africa and Latin America Immunoglobulin Revenue by Application (2024-2029) & (US$ Million)
Table 102. Middle East, Africa and Latin America Immunoglobulin Revenue Grow Rate (CAGR) by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 103. Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2018-2024) & (US$ Million)
Table 104. Middle East, Africa and Latin America Immunoglobulin Revenue by Country (2024-2029) & (US$ Million)
Table 105. Middle East, Africa and Latin America Immunoglobulin Sales by Country (2018-2024) & (K Pcs)
Table 106. Middle East, Africa and Latin America Immunoglobulin Sales by Country (2024-2029) & (K Pcs)
Table 107. Baxter Company Information
Table 108. Baxter Description and Major Businesses
Table 109. Baxter Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 110. Baxter Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 111. Baxter Recent Developments
Table 112. CSL Company Information
Table 113. CSL Description and Major Businesses
Table 114. CSL Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 115. CSL Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 116. CSL Recent Developments
Table 117. Grifols Company Information
Table 118. Grifols Description and Major Businesses
Table 119. Grifols Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 120. Grifols Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 121. Grifols Recent Developments
Table 122. Octapharma Company Information
Table 123. Octapharma Description and Major Businesses
Table 124. Octapharma Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 125. Octapharma Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 126. Octapharma Recent Developments
Table 127. Biotest Company Information
Table 128. Biotest Description and Major Businesses
Table 129. Biotest Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 130. Biotest Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 131. Biotest Recent Developments
Table 132. China National Pharmaceutical Group Company Information
Table 133. China National Pharmaceutical Group Description and Major Businesses
Table 134. China National Pharmaceutical Group Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 135. China National Pharmaceutical Group Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 136. China National Pharmaceutical Group Recent Developments
Table 137. CTBB Company Information
Table 138. CTBB Description and Major Businesses
Table 139. CTBB Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 140. CTBB Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 141. CTBB Recent Developments
Table 142. Hualan Bio Company Information
Table 143. Hualan Bio Description and Major Businesses
Table 144. Hualan Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 145. Hualan Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 146. Hualan Bio Recent Developments
Table 147. RAAS Company Information
Table 148. RAAS Description and Major Businesses
Table 149. RAAS Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 150. RAAS Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 151. RAAS Recent Developments
Table 152. Shanxi Kangbao Biological Company Information
Table 153. Shanxi Kangbao Biological Description and Major Businesses
Table 154. Shanxi Kangbao Biological Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 155. Shanxi Kangbao Biological Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 156. Shanxi Kangbao Biological Recent Developments
Table 157. Shuanglin Bio Pharm Company Information
Table 158. Shuanglin Bio Pharm Description and Major Businesses
Table 159. Shuanglin Bio Pharm Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 160. Shuanglin Bio Pharm Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 161. Shuanglin Bio Pharm Recent Developments
Table 162. Sichuan Yuanda Shuyang Pharmaceutical Company Information
Table 163. Sichuan Yuanda Shuyang Pharmaceutical Description and Major Businesses
Table 164. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 165. Sichuan Yuanda Shuyang Pharmaceutical Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 166. Sichuan Yuanda Shuyang Pharmaceutical Recent Developments
Table 167. Boya Bio Company Information
Table 168. Boya Bio Description and Major Businesses
Table 169. Boya Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 170. Boya Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 171. Boya Bio Recent Developments
Table 172. Jiade Bio Company Information
Table 173. Jiade Bio Description and Major Businesses
Table 174. Jiade Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 175. Jiade Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 176. Jiade Bio Recent Developments
Table 177. Weilun Bio Company Information
Table 178. Weilun Bio Description and Major Businesses
Table 179. Weilun Bio Immunoglobulin Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2018-2024)
Table 180. Weilun Bio Immunoglobulin Product Model Numbers, Pictures, Descriptions and Specifications
Table 181. Weilun Bio Recent Developments
Table 182. Key Raw Materials Lists
Table 183. Raw Materials Key Suppliers Lists
Table 184. Immunoglobulin Distributors List
Table 185. Immunoglobulin Customers List
Table 186. Immunoglobulin Market Trends
Table 187. Immunoglobulin Market Drivers
Table 188. Immunoglobulin Market Challenges
Table 189. Immunoglobulin Market Restraints
Table 190. Research Programs/Design for This Report
Table 191. Key Data Information from Secondary Sources
Table 192. Key Data Information from Primary Sources
List of Figures
Figure 1. Immunoglobulin Product Picture
Figure 2. Global Immunoglobulin Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Immunoglobulin Market Share by Type in 2022 & 2029
Figure 4. Intramuscular Injection Human Immunoglobulin Product Picture
Figure 5. Intravenous Injection Human Immunoglobulin Product Picture
Figure 6. Global Immunoglobulin Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
Figure 7. Global Immunoglobulin Market Share by Application in 2022 & 2029
Figure 8. Prevention of Measles
Figure 9. Infectious Hepatitis
Figure 10. Primary Immunoglobulin Deficiency
Figure 11. Immunoglobulin Report Years Considered
Figure 12. Global Immunoglobulin Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Immunoglobulin Revenue 2018-2029 (US$ Million)
Figure 14. Global Immunoglobulin Revenue Market Share by Region in Percentage: 2022 Versus 2029
Figure 15. Global Immunoglobulin Revenue Market Share by Region (2018-2029)
Figure 16. Global Immunoglobulin Sales 2018-2029 ((K Pcs)
Figure 17. Global Immunoglobulin Sales Market Share by Region (2018-2029)
Figure 18. US & Canada Immunoglobulin Sales YoY (2018-2029) & (K Pcs)
Figure 19. US & Canada Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 20. Europe Immunoglobulin Sales YoY (2018-2029) & (K Pcs)
Figure 21. Europe Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 22. China Immunoglobulin Sales YoY (2018-2029) & (K Pcs)
Figure 23. China Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 24. Asia (excluding China) Immunoglobulin Sales YoY (2018-2029) & (K Pcs)
Figure 25. Asia (excluding China) Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 26. Middle East, Africa and Latin America Immunoglobulin Sales YoY (2018-2029) & (K Pcs)
Figure 27. Middle East, Africa and Latin America Immunoglobulin Revenue YoY (2018-2029) & (US$ Million)
Figure 28. The Immunoglobulin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2022
Figure 29. The Top 5 and 10 Largest Manufacturers of Immunoglobulin in the World: Market Share by Immunoglobulin Revenue in 2022
Figure 30. Global Immunoglobulin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 31. Global Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 32. Global Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 33. Global Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 34. Global Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 35. US & Canada Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 36. US & Canada Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 37. US & Canada Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 38. US & Canada Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 39. US & Canada Immunoglobulin Revenue Share by Country (2018-2029)
Figure 40. US & Canada Immunoglobulin Sales Share by Country (2018-2029)
Figure 41. U.S. Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 42. Canada Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 43. Europe Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 44. Europe Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 45. Europe Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 46. Europe Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 47. Europe Immunoglobulin Revenue Share by Country (2018-2029)
Figure 48. Europe Immunoglobulin Sales Share by Country (2018-2029)
Figure 49. Germany Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 50. France Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 51. U.K. Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 52. Italy Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 53. Russia Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 54. China Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 55. China Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 56. China Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 57. China Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 58. Asia Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 59. Asia Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 60. Asia Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 61. Asia Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 62. Asia Immunoglobulin Revenue Share by Region (2018-2029)
Figure 63. Asia Immunoglobulin Sales Share by Region (2018-2029)
Figure 64. Japan Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 65. South Korea Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 66. China Taiwan Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 67. Southeast Asia Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 68. India Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 69. Middle East, Africa and Latin America Immunoglobulin Sales Market Share by Type (2018-2029)
Figure 70. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Type (2018-2029)
Figure 71. Middle East, Africa and Latin America Immunoglobulin Sales Market Share by Application (2018-2029)
Figure 72. Middle East, Africa and Latin America Immunoglobulin Revenue Market Share by Application (2018-2029)
Figure 73. Middle East, Africa and Latin America Immunoglobulin Revenue Share by Country (2018-2029)
Figure 74. Middle East, Africa and Latin America Immunoglobulin Sales Share by Country (2018-2029)
Figure 75. Brazil Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 76. Mexico Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 77. Turkey Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 78. Israel Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 79. GCC Countries Immunoglobulin Revenue (2018-2029) & (US$ Million)
Figure 80. Immunoglobulin Value Chain
Figure 81. Immunoglobulin Production Process
Figure 82. Channels of Distribution
Figure 83. Distributors Profiles
Figure 84. Bottom-up and Top-down Approaches for This Report
Figure 85. Data Triangulation
Figure 86. Key Executives Interviewed